Novel missense mutation c.539A>G; p.Glu180Gly in keratin 1 causing epidermolytic ichthyosis

Author(s):  
Miho Sashikawa ◽  
Hidetoshi Tsuda ◽  
Mayumi Komine ◽  
Mamitaro Ohtsuki
Author(s):  
Gianluca Tadini ◽  
Sophie Guez ◽  
Michela Brena

Mutations in KRT1 (keratin 1) or KRT10 (keratin 10) underlie a spectrum of diseases known as keratinopathic ichthyoses. Epidermolytic ichthyosis (EI) is caused by heterozygous missense mutations in the genes KRT1 or KRT10, mutations in the gene KRT2 (keratin 2) lead to superficial epidermolytic ichthyosis, and congenital reticular ichthyosiform erythroderma is caused by frameshift mutations in the genes KRT10 or KRT1, which lead to the phenomenon of revertant mosaicism. Epidermolytic ichthyosis is also present in a mosaic pattern known as epidermolytic (acantholytic) nevus, isolated or diffuse. In the latter case, gonadic involvement is possible, leading to a rare pedigree in which a parent with diffuse epidermolytic nevus (linear EI) gives birth to a child affected by EI. We present here an update on the phenotypic presentations of keratinopathic ichthyoses and their molecular mechanisms.


2016 ◽  
Vol 35 (1) ◽  
pp. 19-30 ◽  
Author(s):  
Mondell Avril ◽  
Cheryl Riley

AbstractEpidermolytic ichthyosis (EI) is a rare autosomal dominant genodermatosis that presents at birth as a bullous disease, followed by a lifelong ichthyotic skin disorder.1 Essentially, it is a defective keratinization caused by mutations of keratin 1 (KRT1) or keratin 10 (KRT10) genes, which lead to skin fragility, blistering, and eventually hyperkeratosis. Successful management of EI in the newborn period can be achieved through a thoughtful, directed, and interdisciplinary or multidisciplinary approach that encompasses family support. This condition requires meticulous care to avoid associated morbidities such as infection and dehydration. A better understanding of the disrupted barrier protection of the skin in these patients provides a basis for management with daily bathing, liberal emollients, pain control, and proper nutrition as the mainstays of treatment. In addition, this case presentation will include discussions on the pathophysiology, complications, differential diagnosis, and psychosocial and ethical issues.


2010 ◽  
Vol 162 (4) ◽  
pp. 875-879 ◽  
Author(s):  
M.C. Bolling ◽  
R.S. Bladergroen ◽  
M.A.M. Van Steensel ◽  
M. Willemsen ◽  
M.F. Jonkman ◽  
...  

2015 ◽  
Vol 41 (3) ◽  
pp. 290-293 ◽  
Author(s):  
A. Abdul-Wahab ◽  
T. Takeichi ◽  
L. Liu ◽  
C. Stephens ◽  
M. Akiyama ◽  
...  

2018 ◽  
Vol 6 (1) ◽  
pp. 36
Author(s):  
AhmedM Abdelaal ◽  
AliA Al Raddadi ◽  
TahaH Habibullah ◽  
AngieM Felimban ◽  
HosamA Al Raddadi ◽  
...  

2021 ◽  
Vol 66 (2) ◽  
pp. 224
Author(s):  
Xiaoqing Zhao ◽  
Lihong Chen ◽  
Cheng Quan ◽  
Jie Zheng ◽  
Meng Pan

2018 ◽  
Vol 17 (1) ◽  
pp. 82-84
Author(s):  
Marvin Kuske ◽  
Katja Berndt ◽  
Giada Meinel ◽  
Susanne Abraham ◽  
Vinzenz Oji ◽  
...  

2020 ◽  
Vol 6 (10) ◽  
pp. 1085-1087
Author(s):  
Taylor Gray ◽  
Christopher White ◽  
Maheera Farsi ◽  
Joseph Dyer ◽  
Richard Miller

Sign in / Sign up

Export Citation Format

Share Document